However, the nine study participants were in a relatively advanced stage of infection, as evidenced by the low median CD4+ T cell count of 288 cells/μl, and it is possible that this disease progression status may have influenced the magnitude of HLA-B*57/5801-restricted responses relative to HLA-C responses. This evidence concerns the gene HLA-C and infection.